The mechanism underlying how transcription factors regulate mesenchymal stem cell lineage commitment remains unclear. To determine the role of core-binding factor subunit beta (Cbfβ) in osteoblast lineage commitment, we generated three mouse models by deleting Cbfβ at different osteoblast lineage stages. We demonstrated that the Cbfβ f/f Prx1-Cre, Cbfβ f/f Col2α1-Cre, and Cbfβ f/f Osx-Cre mice exhibited severe osteoporosis with substantial accumulation of marrow adipocytes resembling aged bone from enhanced adipogenesis, indicating that mesenchymal stem cells and osteoblasts can be programed and reprogramed, respectively, into adipocytes. Consistently, Cbfβ-deficient calvarial cells and bone marrow mesenchymal stem cells displayed strong adipogenic potential, with 5-to ∼70-fold increased adipocyte gene expression, which can be rescued by Cbfβ overexpression. Canonical Wnt signaling was impeded in the Cbfβ-deficient cells, with ∼80% decrease of Wnt10b expression. Accordingly, ChIP and luciferase assays demonstrated that Cbfβ/RUNX2 binds to Wnt10b promoter driving Wnt10b expression. Furthermore, Wnt3a suppressed adipogenesis but did not rescue osteoblastogenesis in Cbfβ-deficient cells. Notably, mixing culture of Cbfβ-deficient with normal cells demonstrates that Cbfβ functions not only through WNT paracrine pathway but also through endogenous signaling. Further analysis shows that Cbfβ/RUNX2 inhibits c/ebpα expression at transcriptional level. Our results show that, besides its osteogenic role, Cbfβ governs osteoblast−adipocyte lineage commitment both cell nonautonomously through enhancing β-catenin signaling and cell autonomously through suppressing adipogenesis gene expression to maintain osteoblast lineage commitment, indicating Cbfβ may be a therapeutic target for osteoporosis.
The mechanism underlying how transcription factors regulate mesenchymal stem cell lineage commitment remains unclear. To determine the role of core-binding factor subunit beta (Cbfβ) in osteoblast lineage commitment, we generated three mouse models by deleting Cbfβ at different osteoblast lineage stages. We demonstrated that the Cbfβ f/f Prx1-Cre, Cbfβ f/f Col2α1-Cre, and Cbfβ f/f Osx-Cre mice exhibited severe osteoporosis with substantial accumulation of marrow adipocytes resembling aged bone from enhanced adipogenesis, indicating that mesenchymal stem cells and osteoblasts can be programed and reprogramed, respectively, into adipocytes. Consistently, Cbfβ-deficient calvarial cells and bone marrow mesenchymal stem cells displayed strong adipogenic potential, with 5-to ∼70-fold increased adipocyte gene expression, which can be rescued by Cbfβ overexpression. Canonical Wnt signaling was impeded in the Cbfβ-deficient cells, with ∼80% decrease of Wnt10b expression. Accordingly, ChIP and luciferase assays demonstrated that Cbfβ/RUNX2 binds to Wnt10b promoter driving Wnt10b expression. Furthermore, Wnt3a suppressed adipogenesis but did not rescue osteoblastogenesis in Cbfβ-deficient cells. Notably, mixing culture of Cbfβ-deficient with normal cells demonstrates that Cbfβ functions not only through WNT paracrine pathway but also through endogenous signaling. Further analysis shows that Cbfβ/RUNX2 inhibits c/ebpα expression at transcriptional level. Our results show that, besides its osteogenic role, Cbfβ governs osteoblast−adipocyte lineage commitment both cell nonautonomously through enhancing β-catenin signaling and cell autonomously through suppressing adipogenesis gene expression to maintain osteoblast lineage commitment, indicating Cbfβ may be a therapeutic target for osteoporosis.
Cbfβ | transcription factor | osteoblast | Wnt/β-catenin | bone−fat interaction A ge-associated osteoporosis is a major health problem, which is characterized by an imbalance in bone remodeling and metabolism due to reduced osteoblast-mediated bone formation and increased bone marrow adiposity associated with aging. Bone marrow mesenchymal stem cells (MSCs) are multipotent progenitors that give rise to osteoblasts, adipocytes, and chondrocytes upon specific stimulation for cell differentiation. Notably, the majority of conditions associated with bone loss (e.g., aging, glucocorticoid treatment, and thiazolidinedione treatment) stem from a decreased number of osteoblasts and an increased number of adipocytes in the bone marrow (1) (2) (3) (4) . The preference of MSC differentiation into osteoblast or adipocyte has particular relevance to the maintenance of normal bone homeostasis. It is believed that, under pathologic or aging conditions, switch of MSC commitment promotes increased adipocytes at the expense of osteoblast differentiation in the bone marrow (5) .
Differentiation of MSCs into adipocyte or osteoblast is driven by different transcriptional factors and orchestrated by many signaling pathways (3) . Notably, peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα) can promote adipocyte differentiation (3, 6, 7), whereas Runx2 and Dlx5 direct osteoblast differentiation (8) . Wnt ligands comprise a large family of secreted cysteine-rich and highly hydrophobic glycoproteins that regulate a wide variety of cellular functions (9) . Disruption of the canonical Wnt signaling was shown to reprogram myoblast and preosteoblast cells into the adipocyte lineage (10, 11) . Despite the recent insights, the mechanisms underlying how transcriptional factors regulate β-catenin activity to determine MSC fate, how β-catenin is activated to support healthy bone density and quality, and whether and how different stages of osteoblasts can be reprogramed to adipocytes are unknown.
Cbfβ is a non-DNA-binding partner of Runt-related transcription factors (Runx1, Runx2, and Runx3) (12) (13) (14) . We have recently reported that Cbfβ is involved in skeletal development and osteoblast and chondrocyte differentiation as well as fracture healing (15) (16) (17) (18) . Nevertheless, the function of Cbfβ in osteoblast− adipocyte lineage commitment and maintenance has not yet been determined. To address these questions, we deleted the Cbfβ gene at different osteoblast lineage stages, i.e., MSCs, osteochondroprogenitors, and osteoblast using the Prx1-Cre, Col2α1-Cre, and Osx-Cre mouse lines, respectively (19) (20) (21) . Our Cbfβ conditional deletion revealed that Cbfβ is critical for osteoblast lineage commitment and maintenance through promoting Wnt10b expression and inhibiting the expressions of c/epbα. Osx-Cre mice had reduced bone density compared with their wild-type (WT) littermates ( Fig. 1 A-C). Microcomputed tomography (μCT) analysis of the distal femora of 4-wk-old mouse femurs further confirmed a reduction in bone volume and trabecular bone number, and an increase in trabecular bone separation in the Cbfβ f/f Osx-Cre mice compared with WT controls (Fig. 1D) . Femoral sections from Cbfβ f/f Prx1-Cre, Cbfβ f/f Col2α1-Cre, and Cbfβ f/f Osx-Cre mice were subsequently subjected to further histological analysis (Fig. 1 E-G) . Hematoxylin and eosin (H&E) staining showed that trabecular bone number was largely reduced in the Cbfβ f/f Prx1-Cre (Fig. 1G) , Cbfβ f/f Col2α1-Cre (Fig. 1F) , and Cbfβ f/f Osx-Cre mice (Fig. 1E) . While performing femoral bone histology of the Cbfβ-deficient mice and their WT littermates, we unexpectedly observed dramatic change in the bone marrow fat content. As shown in the high-magnification images, adipocytelike vacuoles accumulated in the bone marrow of Cbfβ f/f Prx1-Cre, Cbfβ f/f Col2α1-Cre, and Cbfβ f/f Osx-Cre mice but not WT mice (Fig. 1 E-G, Right) .
Results

Loss of
To further confirm that the adipocyte-like vacuoles observed in H&E staining slides are adipocytes, we performed Oil Red O staining using femoral frozen sections. Consistently, more adipocytes (red color) were present in the bone marrow of Cbfβ-deficient mice compared with that of WT ( Fig. 2 A-D Fig. 2 C and D) . Our histomorphological analysis of femoral sections of 18-wk-old WT mice by Goldner's trichrome staining revealed that aged mice showed a dramatic decrease in mineralized tissue and an increase in marrow adiposity compared with 2-mo-old controls (Fig. 2E) . The reduced bone density due to aging was further confirmed by μCT analysis (Fig. 2 F and G) . Interestingly, Cbfβ mRNA expression levels in 18-mo-old WT mice were also drastically reduced compared with that of the 2-mo-old group (Fig. 2H) . The results indicate that deficiency of Cbfβ in MSC, osteochondroprogenitor, or early osteoblast leads to high bone marrow adiposity and low bone mass, resembling the bone phenotype in aged WT mice.
Cbfβ-Deficient Calvarial Cells Transdifferentiated into Adipocytes.
The increased bone marrow adiposity caused by knockout of Cbfβ in MSCs, osteochondroprogenitors, or early osteoblasts indicates that the absence of Cbfβ favors adipogenesis. To determine whether Cbfβ-deficient calvarial cells transdifferentiate into adipocytes in vitro, calvarial osteoblast precursor cells derived from WT, Cbfβ f/f Prx1-Cre, and Cbfβ f/f Osx-Cre newborn mice were maintained in the osteogenic medium for 14 d, and adipocyte formation was detected by Oil Red O staining (Fig. 3A) . OsxCre cells were committed to adipocyte lineage (Fig. 3B) (Fig. 3C) . On the contrary, retrovirusmediated overexpression of Cbfβ in Cbfβ f/f Prx1-Cre cells partially rescued osteoblast differentiation (Fig. S1 C and E) and, meanwhile, completely reduced adipocyte formation rates (Fig. S1 B and D) . The deletion and overexpression of Cbfβ were confirmed by Western blot (Fig. S1A) . Interestingly, active β-catenin (nonphosphorylated β-catenin) protein was decreased greatly in the Cbfβ-deficient cells whereas c/ebpα expression was significantly up-regulated (Fig. 3C) . We further examined the expression of adipogenesis-related genes with quantitative real time PCR (qPCR), using cells maintained in the osteogenic medium for 7 d (D7) and 14 d (D14) (Fig. 3 D and E) . At D7 and D14, c/ebpα expression was increased by fivefold in Prx1-Cre cells, compared with the WT cohorts ( Fig. 3 D and E) . Fabp4 expression was also increased dramatically (more than 30-fold in D7, more than 50-fold in D14) in the mutant cells ( Fig. 3 D and E) . Unexpectedly, despite the reduced expression level of active β-catenin protein ( (Fig. S2 B and D) . Cbfβ-deficient MSCs had approximately fourfold more adipocyte (Oil Red O+ cells) formation (Fig. S2 B and D) and approximately threefold less osteoblast (ALP+ cells) formation (Fig. S2 A and C) . Efficient deletion of Cbfβ in Cbfβ f/f Prx1-Cre cells was confirmed by qPCR (Fig. S2D) . Similar to calvarial cells, expression of adipocyte markers (c/ebpα, Fabp4, and Pparγ) was increased in the Cbfβ f/f Prx1-Cre cells, whereas β-catenin mRNA expression was not changed (Fig. S2D) in both D7 and D17.
Cbfβ Inhibits β-Catenin Signaling in Vivo and in Vitro. In deciphering the molecular basis of Cbfβ's roles in osteoblast−adipocyte lineage allocation, mRNA were harvested from WT, Cbfβ f/f Prx1-Cre, and Cbfβ f/f Osx-Cre calvarial cells, which were maintained in the osteogenic medium for 7 d. Genes whose expression has been reported to be regulated by β-catenin (lef1, (Fig. 4A) . The β-catenin needs to translocate into the nuclei to truly exert its transcriptional function; thus we also examined the expression of active β-catenin in the cytoplasm and nuclei, separately. We found a lower level of active β-catenin in both cytoplasm and nuclei of Cbfβ-deficient osteoblasts (Fig. 4B) . The down-regulation of active β-catenin in the whole cell of the mutant cells was confirmed by cellular immunofluorescent (IF) staining (Fig. 4C) . We also detected active β-catenin expression in the newborn and 3-wk-old WT and Cbfβ f/f Osx-Cre femurs (Fig. 4 D and E ; negative controls are presented in Fig. S3A ). We found that the active β-catenin protein level was down-regulated in the hypertrophic chondrocytes of newborn Cbfβ f/f Osx-Cre femurs (Fig. 4D) , and both primary spongiosa and secondary spongiosa of 3-wk-old Cbfβ f/f Osx-Cre femurs (Fig. 4E) , compared with that of the WT littermates. Taken together, our data indicate that β-catenin activity was influenced in the absence of Cbfβ. Osx-Cre cells (Fig. 5 A and B) . Consistently, Wnt10b expression is also down-regulated in the Cbfβ f/f Prx1-Cre and Cbfβ f/f Osx-Cre newborn long bone (Fig. S3B) . Using an 
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Then we constructed the pGL3-Wnt10b promoter containing −159, −111, and +41 binding sites (pro1), and pGL3-Wnt10b promoter containing −111 and +41 binding sites (pro2) (Fig. 5F ). Luciferase analysis revealed that Cbfβ with Runx2 enhances pro1-driven luciferase activity but did not change pro2-driven luciferase activity (Fig. 5G ). Taken together, Cbfβ/Runx2 regulates Wnt10b expression at transcriptional level, by binding to the Wnt10b promoter at the binding sites −159.
Wnt3a Suppresses Lineage Switch of Cbfβ-Deficient Calvarial
Osteoblast. As we showed in Cbfβ Inhibits β-Catenin Signaling in Vivo and in Vitro and Cbfβ Regulates Wnt10b Expression at the Transcriptional Level, Wnt signaling plays an important role in Cbfβ-mediated lineage commitment. Thus, we sought to suppress the adipogenesis from Cbfβ-deficient calvarial cells by potentiating Wnt signaling using Wnt3L conditional medium (Fig. 6 ). Wnt3L conditional medium suppressed adipogenesis of Cbfβ-deficient cells (Fig. 6 A and C) but did not help rescue osteoblast formation (Fig. 6B) . Consistently, Wnt3a dramatically repressed adipocyte-specific gene expression (i.e., fabp4 and pparg) in Cbfβ-deficient cells, rendering their expression level similar to those in WT cells (Fig. 6D) . However, Osx (an osteoblast marker) remained down-regulated in Cbfβ-deficient cells under the treatment of Wnt3L conditional medium (Fig. 6E) . Meanwhile, expression of Cbfβ itself was not changed by Wnt3L conditional medium (Fig. 6E) . 
/GFP
+ ratios 0.28%, 0.55%, 1.5%, and 5.9%, based on GFP-:GFP+ ratios 0:1, 1:1, 3:1, and 6:1, respectively) (Fig. 7C ). Higher ratio of Cbfβ-deficient MSC in the mixing culture also increased the adipocyte formation rate of GFP-Cbfβ-deficient cells (Nile Red
− ratios 2.5%, 12%, and 40%, based on GFP-:GFP+ ratios 1:1, 3:1, 6:1, respectively) (Fig. 7B) . From GFP-:GFP+ ratio 3:1 to 6:1, adipocyte formation rate of GFP-Cbfβ-deficient cells increases by 2.3-fold (Fig. 7B) . Adipocyte formation rate was 4.55-, 8-, and 6.78-fold higher in Cbfβ-deficient cells compared with WT type GFP+ cells (Fig. 7 B and C) based on GFP-:GFP+ ratios 1:1, 3:1, and 6:1, respectively. This observation indicates that, besides autocrine/paracrine signaling, Cbfβ also regulates adipocyte formation through cell-autonomous pathway.
Using the online transcription factor binding site predictive tool (alggen.lsi.upc.es), we identified two binding sites on the c/ebpα promoter for Cbfβ/Runx complex (−281, −2,400) (Fig.  S4A) . ChIP assay showed that Cbfβ/Runx complex binds to the Runx2 and/or Cbfβ expressing vector into C3H10T1/2 cell line. β-GAL expressing vector was also cotransfected. Promoter activity was measured by luciferase normalized to β-GAL. The data were presented as mean ± SEM, n = 20. *P ≤ 0.05 **P ≤ 0.01; NS, not significant.
Wnt10b promoter on the binding sites around 300 bp (predicted binding site −281) but is not likely to bind to the predicted binding site −2,400 (Fig. S4 B-D) . Then we constructed the pGL3-c/ebpα promoter with −281 binding site (pro3,4,5) and without −281 binding site (pro6) (Fig. S4E) . Luciferase analysis revealed that pro3,4,5-driven luciferase activity, but not pro6-driven luciferase activity, is inhibited by Cbfβ overexpression (Fig. S4F) . Furthermore, pro3,4,5-driven luciferase activity is more notably inhibited by Cbfβ/Runx2 cotransfection (Fig. S4F) . Taken together, Cbfβ/Runx2 regulates c/ebpα expression at transcriptional level, by binding to the c/ebpα promoter at the binding site −281. Besides Wnt signaling, Cbfβ-mediated c/ebpα also contributes to lineage commitment.
Discussion
Taken together, our data demonstrate that Cbfβ plays a critical role in the maintenance of osteoblast lineage, and the switch from osteoblastogensis to adipogenesis can occur at any stage of osteoblast differentiation (Fig. 7D) . Importantly, Cbfβ suppresses adipogenesis through Wnt signaling and c/ebpα expression, whereas it regulates osteoblast differentiation through different mechanisms (Fig. 7D) . Osx-Cre mouse models result in bone marrow adipocyte accumulation in vivo, resembling the conditions associated with osteoporosis in aging human bone (Figs. 1-3 ). Our data show that, besides MSCs, Cbfβ-deficient osteoblasts lineage cells at different stages of osteoblastogenesis can be reprogramed into adipocytes. This finding indicates the importance of Cbfβ in osteoblast lineage commitment and maintenance as well as in adipogenesis in aging bone marrow, and that the switch from osteoblastogensis to adipogenesis can occur at any stage of osteoblast differentiation (Fig. 7D) .
Role of Cbfβ in MSC Differentiation and Osteoporosis. Our previous studies also showed that Cbfβ deficiency inhibited chondrocyte proliferation and hypertrophy, and impaired growth plate development due to disrupted Ihh−PTHrP regulatory loop (19) (20) (21) , which in turn regulated endochondral bone formation. Our previous and current studies showed that Ihh and β-catenin signaling plays a role at distinct differentiation stages (19) . Although β-catenin signaling is a critical regulator of bone marrow adipocyte (10, 11, 22) , adipogenic role of Ihh is unclear. Thus, regarding Cbfβ's role in osteoblast−adipocyte lineage commitment, canonical Wnt might be more critical than Ihh pathway.
Runx/Cbfβ Complex Promotes Wnt10b/β-Catenin Signaling and Inhibits c/ebpa Expression to Inhibit Lineage Switch into Adipocytes. Wnt/ β-catenin directs mesenchymal cell commitment to the osteogenic lineage and prevents adipogenic differentiation, resulting in increased new bone formation (10, 11, 22) . Overexpression of canonical Wnt ligand Wnt10b induces higher bone mass in mice, and Wnt10b inhibits differentiation of preadipocytes and blocks adipose tissue development (23, 24) . Interestingly, Wnt10b is downregulated in Cbfβ-deficient cells and tissues, and ChIP plus promoter activity assay showed that Wnt10b is up-regulated by Cbfβ f/f Prx1-Cre calvarial cells cultured in osteogenic medium or osteogenic medium supplemented with Wnt3L conditional medium, normalized to hprt1. The data were presented as mean ± SEM, n = 10. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.005; NS, not significant.
at the transcriptional level (Fig. 5) . In addition, adipocyte differentiation can be suppressed but osteoblast differentiation cannot be rescued in the presence of Wnt3L conditional medium containing Wnt3a (Fig. 6 ). Those observations indicate that the Runx/ Cbfβ complex inhibits programing and reprograming of MSCs and osteoblast into adipocytes through Wnt10b/β-catenin signaling, whereas regulation of osteoblast differentiation by Runx/Cbfβ is independent of this pathway (Fig. 7D) .
In the experiment of mixing culture of Cbfβ-deficient and GFP+ normal cells, in the presence of higher ratio of Cbfβ-deficient cells, both Cbfβ-deficient and GFP+ WT cells have higher adipocyte formation rate, confirming that Cbfβ inhibits adipocyte formation through paracrine Wnt10b signaling (Fig. 7 A-C) . However, adipocyte formation rate is always much higher in the Cbfβ-deficient cells regardless of mixing ratios, indicating that Cbfβ also inhibits adipocyte differentiation cell-autonomously (Fig. 7 A-C) . Further studies using ChIP and luciferase assay prove that Cbfβ/ Runx2 complex inhibits the expression of c/ebpa, an important adipogenic transcriptional factor, at transcriptional level (Fig. S4) . Taken together, our data show that Cbfβ regulates osteoblast differentiation from both endogenous and paracrine signaling (Fig. 7D ).
Cbfβ May Be Essential for Prevention of Human Age-Associated
Osteoporosis Resulting from Elevated Adipogenesis. Our results showed, along with reduced bone mineral density in aged WT mice, Cbfβ expression was dramatically reduced in aged mice, indicating that low Cbfβ expression might be a major cause of age-related osteoporosis with increased adipogenesis (Fig. 2) . The fact that lineage switch from osteoblastogensis to adipogenesis can occur at multiple stages of osteoblast differentiation in the Cbfβ-deficient cells (Figs. 1 and 2) demonstrates that Cbfβ may be essential for prevention of human age-associated osteoporosis due to elevated adipogenesis. Further understanding the mechanism underlying osteoblast−adipocyte lineage allocation will fill an important knowledge gap and may facilitate the development of novel bone loss therapeutics while minimizing the adverse side effects on bone hemostasis.
Materials and Methods
The study was approved by the University of Alabama at Birmingham (UAB) Animal Care and Use Committee, conformed to National Institutes of Health guidelines, and followed all recommendations of Animal Research: Reporting in Vivo Experiments guidelines. For more detailed description, please refer to SI Materials and Methods. For primer sequences please refer to Tables S1-S3.
Generation of Cbfβ CKO Mice. Cbfβ f/f mice and mice with tissue-specific promoter-driven Cre were crossed to generate heterozygous mice (15) (16) (17) (18) . Histology and tissue preparation were performed as described previously (25) .
Immunohistochemistry (IHC) and IF staining were performed using a commercial kit (CAT#BMK-2202; Vector Laboratories) (25) (26) (27) .
Cell Culture and Osteoblast Function. Osteoblastogenesis from primary calvarial cells and bone marrow MSC was performed as described (15, 28) .
Gene expression analyses (Western blot and qRT-PCR) were performed as previously described (25, 26) .
Nile Red Staining. Differentiated cells were stained by 25 ng/mL Nile Red and counterstained by DAPI.
ChIP was performed as described using primary osteoblast lysates and MAGnify ChIP system (Cat#492024; Invitrogen) (15) .
Promoter Luciferase Assay. Promoter assay-related plasmids were transfected into C3H10T1/2 cells. Luciferase was detected and analyzed (15) .
Statistical Analysis. The number of animals to be used in this study was determined in accordance with power analysis and our previous studies (25, 26) . Detailed materials and methods can also be retained in SI Materials and Methods.
